Shree Ganesh Remedies Ltd

Shree Ganesh Remedies Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 12 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 23 April 2026, providing investors with the latest comprehensive analysis.

Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Shree Ganesh Remedies Ltd has seen a notable shift in its valuation parameters, moving from a fair to an expensive rating, driven primarily by its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This change contrasts with its historical valuation and peer group metrics, raising questions about the stock's price attractiveness in the Pharmaceuticals & Biotechnology sector.

Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 April 2026, providing investors with the latest insights into its performance and outlook.

Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a marked shift in technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action and technical parameters suggest increasing downside pressure, raising concerns for investors amid a challenging market backdrop.

Shree Ganesh Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade amid a challenging market backdrop. Despite a recent downgrade to a Strong Sell rating, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a recalibration of investor expectations, warranting a closer examination of its price attractiveness relative to peers and historical benchmarks.

Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Shree Ganesh Remedies Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 February 2026, providing investors with the latest insights into its performance and outlook.

Shree Ganesh Remedies Ltd has seen a notable shift in its valuation parameters, moving from fair to expensive territory, as reflected in its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios. Despite a recent uptick in share price, the company’s valuation now stands out against both historical averages and peer benchmarks, raising questions about price attractiveness amid mixed financial performance and market returns.

Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 04 February 2026, providing investors with the most up-to-date analysis.

Shree Ganesh Remedies Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a recent price surge of 6.79% to ₹455.00, the stock’s overall momentum and technical indicators present a nuanced picture for investors navigating the Pharmaceuticals & Biotechnology sector.

Shree Ganesh Remedies Ltd, a player in the Pharmaceuticals & Biotechnology sector, is currently navigating a challenging technical landscape. Despite a modest daily price gain, the stock’s broader momentum indicators reveal a shift towards bearishness, with key technical parameters signalling caution for investors.

Shree Ganesh Remedies Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest daily price gain, the stock remains under pressure over longer periods, with technical indicators suggesting a cautious outlook for investors in the Pharmaceuticals & Biotechnology sector.

Shree Ganesh Remedies Ltd touched a fresh 52-week low of Rs.381.1 today, marking a significant decline in its stock price amid persistent downward momentum. The pharmaceutical company’s shares opened sharply lower and underperformed the sector, reflecting ongoing pressures in its financial performance and market positioning.

Shree Ganesh Remedies Ltd has reported a marked deterioration in its financial performance for the quarter ended December 2025, with key metrics such as revenue, profitability, and returns on capital contracting sharply. This downturn contrasts with the company’s historically robust growth trajectory and comes amid broader sectoral headwinds in Pharmaceuticals & Biotechnology.